Development and Evaluation of a Boronate Inhibitor of γ-Glutamyl Transpeptidase
γ-Glutamyl transpeptidase (γ-GT) plays a central role in the metabolism of glutathione and is also a marker for neoplasia and cell transformation. We have investigated the compound l-2-amino-4-boronobutanoic acid (ABBA) as a structural analog of the putative ternary complex formed by the enzyme, l-s...
Gespeichert in:
Veröffentlicht in: | Archives of biochemistry and biophysics 2001-01, Vol.385 (2), p.250-258 |
---|---|
Hauptverfasser: | , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 258 |
---|---|
container_issue | 2 |
container_start_page | 250 |
container_title | Archives of biochemistry and biophysics |
container_volume | 385 |
creator | London, Robert E. Gabel, Scott A. |
description | γ-Glutamyl transpeptidase (γ-GT) plays a central role in the metabolism of glutathione and is also a marker for neoplasia and cell transformation. We have investigated the compound l-2-amino-4-boronobutanoic acid (ABBA) as a structural analog of the putative ternary complex formed by the enzyme, l-serine, and borate, proposed to function as a transition state analog inhibitor. ABBA was found to be a potent inhibitor of the enzyme, with Ki = 17 nM using typical assay conditions (pH 8, γ-glutamyl-p-nitroanilide substrate, 20 mM glycyl-glycine acceptor). ABBA is a stable amino acid analog with pK values determined from 13C and 11B NMR to be 2.3, 11.0 (amino titration), and 7.9 (boronate titration). The structural similarity to glutamate suggested that it might function as a glutamate analog for some glutamate-dependent enzymes or receptors. Transamination of pyruvate by ABBA to yield alanine in the presence of glutamic pyruvic transaminase was demonstrated by 13C NMR. The 2- keto-4-boronobutanoicacid transamination product is apparently fairly labile to hydrolysis, leading to formation of 2-ketobutanoic acid plus borate. The latter is also subsequently transaminated to yield 2-aminobutanoic acid. Both of these metabolites were observed in the 13C NMR spectrum. However, the corresponding transamination of oxaloacetate by ABBA in the presence of glutamic oxaloacetic transaminase was not observed. Effects of ABBA on the growth of cultured rat liver cell lines ARL-15C1 (nontumorigenic, low γ-GT activity) and ARL-16T2 (tumorigenic, high γ-GT activity) were also investigated, both in standard Williams Media as well as in a low cysteine growth medium. A high concentration (1 mM) of ABBA inhibited the growth of both cell lines in both media, with the degree of inhibition greater in the low cysteine medium. Alternatively, growth inhibition by 10 μM ABBA could be observed only in the low cysteine media. In general, there were no significant differences between the two cell lines in terms of sensitivity to ABBA. |
doi_str_mv | 10.1006/abbi.2000.2169 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_70886859</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0003986100921696</els_id><sourcerecordid>70886859</sourcerecordid><originalsourceid>FETCH-LOGICAL-c340t-a1098cb3e642066caf89e129e78ec54f77e9da7c90825075e4f0ec88eaa65fed3</originalsourceid><addsrcrecordid>eNp1kE1LxDAQhoMoun5cPUpP3rpO-pGmR78VBD2s5zBNpxhpm5qkC_u7_B_-Jlt2wZOngZdnXmYexs45LDmAuMKqMssEAJYJF-UeW3AoRQypzPbZYorTuJSCH7Fj7z8BOM9EcsiOOE-FBMgX7O2O1tTaoaM-RNjX0f0a2xGDsX1kmwijG-tsj4Gi5_7DVCZYN-c_3_FjOwbsNm20ctj7gYZgavR0yg4abD2d7eYJe3-4X90-xS-vj8-31y-xTjMIMU53Sl2lJLIEhNDYyJJ4UlIhSedZUxRU1ljoEmSSQ5FT1gBpKQlR5A3V6Qm73PYOzn6N5IPqjNfUttiTHb0qQEoh83ICl1tQO-u9o0YNznToNoqDmh2q2aGaHarZ4bRwsWseq47qP3wnbQLkFqDpv7Uhp7w21GuqjSMdVG3Nf92_fumBUA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>70886859</pqid></control><display><type>article</type><title>Development and Evaluation of a Boronate Inhibitor of γ-Glutamyl Transpeptidase</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>London, Robert E. ; Gabel, Scott A.</creator><creatorcontrib>London, Robert E. ; Gabel, Scott A.</creatorcontrib><description>γ-Glutamyl transpeptidase (γ-GT) plays a central role in the metabolism of glutathione and is also a marker for neoplasia and cell transformation. We have investigated the compound l-2-amino-4-boronobutanoic acid (ABBA) as a structural analog of the putative ternary complex formed by the enzyme, l-serine, and borate, proposed to function as a transition state analog inhibitor. ABBA was found to be a potent inhibitor of the enzyme, with Ki = 17 nM using typical assay conditions (pH 8, γ-glutamyl-p-nitroanilide substrate, 20 mM glycyl-glycine acceptor). ABBA is a stable amino acid analog with pK values determined from 13C and 11B NMR to be 2.3, 11.0 (amino titration), and 7.9 (boronate titration). The structural similarity to glutamate suggested that it might function as a glutamate analog for some glutamate-dependent enzymes or receptors. Transamination of pyruvate by ABBA to yield alanine in the presence of glutamic pyruvic transaminase was demonstrated by 13C NMR. The 2- keto-4-boronobutanoicacid transamination product is apparently fairly labile to hydrolysis, leading to formation of 2-ketobutanoic acid plus borate. The latter is also subsequently transaminated to yield 2-aminobutanoic acid. Both of these metabolites were observed in the 13C NMR spectrum. However, the corresponding transamination of oxaloacetate by ABBA in the presence of glutamic oxaloacetic transaminase was not observed. Effects of ABBA on the growth of cultured rat liver cell lines ARL-15C1 (nontumorigenic, low γ-GT activity) and ARL-16T2 (tumorigenic, high γ-GT activity) were also investigated, both in standard Williams Media as well as in a low cysteine growth medium. A high concentration (1 mM) of ABBA inhibited the growth of both cell lines in both media, with the degree of inhibition greater in the low cysteine medium. Alternatively, growth inhibition by 10 μM ABBA could be observed only in the low cysteine media. In general, there were no significant differences between the two cell lines in terms of sensitivity to ABBA.</description><identifier>ISSN: 0003-9861</identifier><identifier>EISSN: 1096-0384</identifier><identifier>DOI: 10.1006/abbi.2000.2169</identifier><identifier>PMID: 11368005</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Alanine - metabolism ; Alanine Transaminase - metabolism ; Aminobutyrates - metabolism ; Animals ; Aspartate Aminotransferases - metabolism ; Binding Sites ; Boron Compounds - chemistry ; Boron Compounds - pharmacology ; Carbon Isotopes ; Cell Division - drug effects ; Cell Line ; Culture Media - chemistry ; Culture Media - pharmacology ; Cysteine - pharmacology ; gamma-Glutamyltransferase - antagonists & inhibitors ; gamma-Glutamyltransferase - metabolism ; Glutamine - analogs & derivatives ; Glutamine - metabolism ; Hydrogen-Ion Concentration ; Kinetics ; Liver ; Magnetic Resonance Spectroscopy ; Oxaloacetic Acid - metabolism ; Protons ; Pyruvic Acid - metabolism ; Rats</subject><ispartof>Archives of biochemistry and biophysics, 2001-01, Vol.385 (2), p.250-258</ispartof><rights>2001 Academic Press</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c340t-a1098cb3e642066caf89e129e78ec54f77e9da7c90825075e4f0ec88eaa65fed3</citedby><cites>FETCH-LOGICAL-c340t-a1098cb3e642066caf89e129e78ec54f77e9da7c90825075e4f0ec88eaa65fed3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1006/abbi.2000.2169$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,778,782,3539,27907,27908,45978</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11368005$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>London, Robert E.</creatorcontrib><creatorcontrib>Gabel, Scott A.</creatorcontrib><title>Development and Evaluation of a Boronate Inhibitor of γ-Glutamyl Transpeptidase</title><title>Archives of biochemistry and biophysics</title><addtitle>Arch Biochem Biophys</addtitle><description>γ-Glutamyl transpeptidase (γ-GT) plays a central role in the metabolism of glutathione and is also a marker for neoplasia and cell transformation. We have investigated the compound l-2-amino-4-boronobutanoic acid (ABBA) as a structural analog of the putative ternary complex formed by the enzyme, l-serine, and borate, proposed to function as a transition state analog inhibitor. ABBA was found to be a potent inhibitor of the enzyme, with Ki = 17 nM using typical assay conditions (pH 8, γ-glutamyl-p-nitroanilide substrate, 20 mM glycyl-glycine acceptor). ABBA is a stable amino acid analog with pK values determined from 13C and 11B NMR to be 2.3, 11.0 (amino titration), and 7.9 (boronate titration). The structural similarity to glutamate suggested that it might function as a glutamate analog for some glutamate-dependent enzymes or receptors. Transamination of pyruvate by ABBA to yield alanine in the presence of glutamic pyruvic transaminase was demonstrated by 13C NMR. The 2- keto-4-boronobutanoicacid transamination product is apparently fairly labile to hydrolysis, leading to formation of 2-ketobutanoic acid plus borate. The latter is also subsequently transaminated to yield 2-aminobutanoic acid. Both of these metabolites were observed in the 13C NMR spectrum. However, the corresponding transamination of oxaloacetate by ABBA in the presence of glutamic oxaloacetic transaminase was not observed. Effects of ABBA on the growth of cultured rat liver cell lines ARL-15C1 (nontumorigenic, low γ-GT activity) and ARL-16T2 (tumorigenic, high γ-GT activity) were also investigated, both in standard Williams Media as well as in a low cysteine growth medium. A high concentration (1 mM) of ABBA inhibited the growth of both cell lines in both media, with the degree of inhibition greater in the low cysteine medium. Alternatively, growth inhibition by 10 μM ABBA could be observed only in the low cysteine media. In general, there were no significant differences between the two cell lines in terms of sensitivity to ABBA.</description><subject>Alanine - metabolism</subject><subject>Alanine Transaminase - metabolism</subject><subject>Aminobutyrates - metabolism</subject><subject>Animals</subject><subject>Aspartate Aminotransferases - metabolism</subject><subject>Binding Sites</subject><subject>Boron Compounds - chemistry</subject><subject>Boron Compounds - pharmacology</subject><subject>Carbon Isotopes</subject><subject>Cell Division - drug effects</subject><subject>Cell Line</subject><subject>Culture Media - chemistry</subject><subject>Culture Media - pharmacology</subject><subject>Cysteine - pharmacology</subject><subject>gamma-Glutamyltransferase - antagonists & inhibitors</subject><subject>gamma-Glutamyltransferase - metabolism</subject><subject>Glutamine - analogs & derivatives</subject><subject>Glutamine - metabolism</subject><subject>Hydrogen-Ion Concentration</subject><subject>Kinetics</subject><subject>Liver</subject><subject>Magnetic Resonance Spectroscopy</subject><subject>Oxaloacetic Acid - metabolism</subject><subject>Protons</subject><subject>Pyruvic Acid - metabolism</subject><subject>Rats</subject><issn>0003-9861</issn><issn>1096-0384</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2001</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kE1LxDAQhoMoun5cPUpP3rpO-pGmR78VBD2s5zBNpxhpm5qkC_u7_B_-Jlt2wZOngZdnXmYexs45LDmAuMKqMssEAJYJF-UeW3AoRQypzPbZYorTuJSCH7Fj7z8BOM9EcsiOOE-FBMgX7O2O1tTaoaM-RNjX0f0a2xGDsX1kmwijG-tsj4Gi5_7DVCZYN-c_3_FjOwbsNm20ctj7gYZgavR0yg4abD2d7eYJe3-4X90-xS-vj8-31y-xTjMIMU53Sl2lJLIEhNDYyJJ4UlIhSedZUxRU1ljoEmSSQ5FT1gBpKQlR5A3V6Qm73PYOzn6N5IPqjNfUttiTHb0qQEoh83ICl1tQO-u9o0YNznToNoqDmh2q2aGaHarZ4bRwsWseq47qP3wnbQLkFqDpv7Uhp7w21GuqjSMdVG3Nf92_fumBUA</recordid><startdate>20010115</startdate><enddate>20010115</enddate><creator>London, Robert E.</creator><creator>Gabel, Scott A.</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20010115</creationdate><title>Development and Evaluation of a Boronate Inhibitor of γ-Glutamyl Transpeptidase</title><author>London, Robert E. ; Gabel, Scott A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c340t-a1098cb3e642066caf89e129e78ec54f77e9da7c90825075e4f0ec88eaa65fed3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2001</creationdate><topic>Alanine - metabolism</topic><topic>Alanine Transaminase - metabolism</topic><topic>Aminobutyrates - metabolism</topic><topic>Animals</topic><topic>Aspartate Aminotransferases - metabolism</topic><topic>Binding Sites</topic><topic>Boron Compounds - chemistry</topic><topic>Boron Compounds - pharmacology</topic><topic>Carbon Isotopes</topic><topic>Cell Division - drug effects</topic><topic>Cell Line</topic><topic>Culture Media - chemistry</topic><topic>Culture Media - pharmacology</topic><topic>Cysteine - pharmacology</topic><topic>gamma-Glutamyltransferase - antagonists & inhibitors</topic><topic>gamma-Glutamyltransferase - metabolism</topic><topic>Glutamine - analogs & derivatives</topic><topic>Glutamine - metabolism</topic><topic>Hydrogen-Ion Concentration</topic><topic>Kinetics</topic><topic>Liver</topic><topic>Magnetic Resonance Spectroscopy</topic><topic>Oxaloacetic Acid - metabolism</topic><topic>Protons</topic><topic>Pyruvic Acid - metabolism</topic><topic>Rats</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>London, Robert E.</creatorcontrib><creatorcontrib>Gabel, Scott A.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Archives of biochemistry and biophysics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>London, Robert E.</au><au>Gabel, Scott A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Development and Evaluation of a Boronate Inhibitor of γ-Glutamyl Transpeptidase</atitle><jtitle>Archives of biochemistry and biophysics</jtitle><addtitle>Arch Biochem Biophys</addtitle><date>2001-01-15</date><risdate>2001</risdate><volume>385</volume><issue>2</issue><spage>250</spage><epage>258</epage><pages>250-258</pages><issn>0003-9861</issn><eissn>1096-0384</eissn><abstract>γ-Glutamyl transpeptidase (γ-GT) plays a central role in the metabolism of glutathione and is also a marker for neoplasia and cell transformation. We have investigated the compound l-2-amino-4-boronobutanoic acid (ABBA) as a structural analog of the putative ternary complex formed by the enzyme, l-serine, and borate, proposed to function as a transition state analog inhibitor. ABBA was found to be a potent inhibitor of the enzyme, with Ki = 17 nM using typical assay conditions (pH 8, γ-glutamyl-p-nitroanilide substrate, 20 mM glycyl-glycine acceptor). ABBA is a stable amino acid analog with pK values determined from 13C and 11B NMR to be 2.3, 11.0 (amino titration), and 7.9 (boronate titration). The structural similarity to glutamate suggested that it might function as a glutamate analog for some glutamate-dependent enzymes or receptors. Transamination of pyruvate by ABBA to yield alanine in the presence of glutamic pyruvic transaminase was demonstrated by 13C NMR. The 2- keto-4-boronobutanoicacid transamination product is apparently fairly labile to hydrolysis, leading to formation of 2-ketobutanoic acid plus borate. The latter is also subsequently transaminated to yield 2-aminobutanoic acid. Both of these metabolites were observed in the 13C NMR spectrum. However, the corresponding transamination of oxaloacetate by ABBA in the presence of glutamic oxaloacetic transaminase was not observed. Effects of ABBA on the growth of cultured rat liver cell lines ARL-15C1 (nontumorigenic, low γ-GT activity) and ARL-16T2 (tumorigenic, high γ-GT activity) were also investigated, both in standard Williams Media as well as in a low cysteine growth medium. A high concentration (1 mM) of ABBA inhibited the growth of both cell lines in both media, with the degree of inhibition greater in the low cysteine medium. Alternatively, growth inhibition by 10 μM ABBA could be observed only in the low cysteine media. In general, there were no significant differences between the two cell lines in terms of sensitivity to ABBA.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>11368005</pmid><doi>10.1006/abbi.2000.2169</doi><tpages>9</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0003-9861 |
ispartof | Archives of biochemistry and biophysics, 2001-01, Vol.385 (2), p.250-258 |
issn | 0003-9861 1096-0384 |
language | eng |
recordid | cdi_proquest_miscellaneous_70886859 |
source | MEDLINE; Elsevier ScienceDirect Journals |
subjects | Alanine - metabolism Alanine Transaminase - metabolism Aminobutyrates - metabolism Animals Aspartate Aminotransferases - metabolism Binding Sites Boron Compounds - chemistry Boron Compounds - pharmacology Carbon Isotopes Cell Division - drug effects Cell Line Culture Media - chemistry Culture Media - pharmacology Cysteine - pharmacology gamma-Glutamyltransferase - antagonists & inhibitors gamma-Glutamyltransferase - metabolism Glutamine - analogs & derivatives Glutamine - metabolism Hydrogen-Ion Concentration Kinetics Liver Magnetic Resonance Spectroscopy Oxaloacetic Acid - metabolism Protons Pyruvic Acid - metabolism Rats |
title | Development and Evaluation of a Boronate Inhibitor of γ-Glutamyl Transpeptidase |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-16T22%3A07%3A36IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Development%20and%20Evaluation%20of%20a%20Boronate%20Inhibitor%20of%20%CE%B3-Glutamyl%20Transpeptidase&rft.jtitle=Archives%20of%20biochemistry%20and%20biophysics&rft.au=London,%20Robert%20E.&rft.date=2001-01-15&rft.volume=385&rft.issue=2&rft.spage=250&rft.epage=258&rft.pages=250-258&rft.issn=0003-9861&rft.eissn=1096-0384&rft_id=info:doi/10.1006/abbi.2000.2169&rft_dat=%3Cproquest_cross%3E70886859%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=70886859&rft_id=info:pmid/11368005&rft_els_id=S0003986100921696&rfr_iscdi=true |